Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Colistimethate sodium
Drug ID BADD_D00524
Description Colistimethate is an antibiotic that has been shown to have bactericidal activity against aerobic gram-negative microorganisms. Colistimethate is particularly indicated when the infection is caused by sensitive strains of Pseudomonas aeruginosa.
Indications and Usage For the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, particularly _Pseudomonas aeruginosa_.
Marketing Status approved; vet_approved
ATC Code Not Available
DrugBank ID DB01111
KEGG ID D02049
MeSH ID C004691
PubChem ID 216258
TTD Drug ID D0Q3BV
NDC Product Code 24507-005; 63323-393; 42023-131; 63552-010; 23155-193; 45932-0016; 45932-0053; 70594-023; 14789-201; 42513-0007; 45932-0015
UNII XW0E5YS77G
Synonyms colistinmethanesulfonic acid | colistimethate | colistimethate sodium | colistin sodium methanesulfonate | colistimethate, disodium salt
Chemical Information
Molecular Formula C58H105N16Na5O28S5
CAS Registry Number 12705-41-8
SMILES CCC(C)CCCCC(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC(C(C)O)C(=O)NC(CCNCS(=O)(=O)[O-])C(=O )NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCNCS(=O)(=O)[O-])CC (C)C)CC(C)C)CCNCS(=O)(=O)[O-])CCNCS(=O)(=O)[O-])C(C)O.[Na+].[Na+].[Na+].[Na+].[N a+]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Immune system disorder10.02.01.001--Not Available
Laryngeal pain22.12.03.010--
Lower respiratory tract infection22.07.01.002; 11.01.09.002--Not Available
Nausea07.01.07.001--
Nephropathy toxic20.05.03.002; 12.03.01.010--Not Available
Nervous system disorder17.02.10.001--Not Available
Oliguria20.01.03.004--Not Available
Paraesthesia23.03.03.094; 17.02.06.005--
Productive cough22.02.03.005--
Proteinuria20.02.01.011--
Pruritus23.03.12.001--
Pyrexia08.05.02.003--
Rales22.12.01.011--Not Available
Rash23.03.13.001--Not Available
Respiratory distress22.02.01.012--Not Available
Salivary hypersecretion07.06.01.009--Not Available
Seizure17.12.03.001--
Somnolence19.02.05.003; 17.02.04.006--
Thirst14.03.02.007; 08.01.09.021--Not Available
Throat irritation22.12.03.029; 07.05.05.037--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Toothache07.09.06.001--
Urethral disorder20.07.01.002--Not Available
Urinary tract disorder20.08.01.001--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vertigo17.02.12.002; 04.04.01.003--
Vomiting07.01.07.003--
Wheezing22.03.01.009--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages